Metraipolis › archive › dc_77635f29cf49
Zoledronic acid for chronic kidney disease-associated osteoporosis — Europe PMC PMID:41739309
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41739309
- DOI
- 10.1007/s11657-[numero omesso]-2
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T07:52:52.648Z
- SHA-256 of the archived text
bb8c80e603be079321819e89fa9bd6eceeeff225a3644c558482665e27b87a78- Stable URL of this page
https://metraipolis.com/documento/dc_77635f29cf49
How to cite
Zoledronic acid for chronic kidney disease-associated osteoporosis — Europe PMC PMID:41739309 — Europe PMC (en), https://europepmc.org/article/MED/41739309 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_77635f29cf49 (Metraipolis archive dc_77635f29cf49, sha256 bb8c80e603be079321819e89fa9bd6eceeeff225a3644c558482665e27b87a78)
BibTeX
@misc{dc77635f29cf49,
title = {Zoledronic acid for chronic kidney disease-associated osteoporosis — Europe PMC PMID:41739309},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41739309},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_77635f29cf49; sha256 bb8c80e603be079321819e89fa9bd6eceeeff225a3644c558482665e27b87a78},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41739309. Agents can read the archived copy with the MCP tool read_document.